These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11167672)

  • 1. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.
    Daley-Yates PT; Baker RC
    Br J Clin Pharmacol; 2001 Jan; 51(1):103-5. PubMed ID: 11167672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
    Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
    Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
    Derendorf H; Munzel U; Petzold U; Maus J; Mascher H; Hermann R; Bousquet J
    Br J Clin Pharmacol; 2012 Jul; 74(1):125-33. PubMed ID: 22356350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol.
    Messina JC; Offman E; Carothers JL; Mahmoud RA
    Clin Ther; 2019 Nov; 41(11):2343-2356. PubMed ID: 31732149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays.
    Daley-Yates PT; Kunka RL; Yin Y; Andrews SM; Callejas S; Ng C
    Eur J Clin Pharmacol; 2004 Jun; 60(4):265-8. PubMed ID: 15114430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
    Brutsche MH; Brutsche IC; Munawar M; Langley SJ; Masterson CM; Daley-Yates PT; Brown R; Custovic A; Woodcock A
    Lancet; 2000 Aug; 356(9229):556-61. PubMed ID: 10950233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis.
    Davis GA; Rudy AC; Archer SM; Wermeling DP; McNamara PJ
    Pharmacotherapy; 2004 Jan; 24(1):26-32. PubMed ID: 14740785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluticasone propionate aqueous nasal spray for the treatment of chronic sinusitis with eosinophil].
    Ohta Y; Tsubaki K; Yamamoto M; Makino N; Ishikawa T; Ichimura K
    Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):157-62. PubMed ID: 16615430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of nasal drop and nasal spray applications of fluticasone propionate in nasal polyps.
    Demirel T; Orhan KS; Keleş N; Değer K
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(1):1-6. PubMed ID: 18443395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.
    Crim C; Pierre LN; Daley-Yates PT
    Clin Ther; 2001 Sep; 23(9):1339-54. PubMed ID: 11589253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human pharmacology of fluticasone propionate.
    Harding SM
    Respir Med; 1990 Nov; 84 Suppl A():25-9. PubMed ID: 2287792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
    Hallén H; Enerdal J; Graf P
    Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological availability of inhaled fluticasone propionate in horses.
    Laan TT; Westermann CM; Dijkstra AV; van Nieuwstadt RA; Fink-Gremmels J
    Vet Rec; 2004 Sep; 155(12):361-4. PubMed ID: 15493604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
    Fowler SJ; Orr LC; Wilson AM; Sims EJ; Lipworth BJ
    Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis.
    van As A; Bronsky E; Grossman J; Meltzer E; Ratner P; Reed C
    Ann Allergy; 1991 Aug; 67(2 Pt 1):156-62. PubMed ID: 1867454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis.
    Andersson M; Berglund R; Greiff L; Hammarlund A; Hedbys L; Malcus I; Nilsson P; Olsson P; Sjölin IL; Synnerstad B
    Rhinology; 1995 Mar; 33(1):18-21. PubMed ID: 7784789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J; Caldwell MF; Wolthers OD
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical properties of fluticasone propionate nasal drops: a new formulation.
    Denyer S
    Allergy; 1999; 54 Suppl 53():17-20. PubMed ID: 10442546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis.
    Nathan RA; Bronsky EA; Fireman P; Grossman J; LaForce CF; Lemanske RF; Pearlman DS; Ratner PH; Rogenes PR
    Ann Allergy; 1991 Sep; 67(3):332-8. PubMed ID: 1897811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic bioavailability of fluticasone proprionate.
    Lipworth BJ
    Br J Clin Pharmacol; 2001 Oct; 52(4):457-60. PubMed ID: 11678793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.